Advertisement

Advertisement

COLL Stock Latest News

Leerink bullish on Collegium Pharmaceutical, initiates with an Outperform

The FlyLeerink bullish on Collegium Pharmaceutical, initiates with an Outperform

Collegium Pharmaceutical initiated with an Outperform at Leerink

PremiumThe Fly

Collegium Pharmaceutical initiated with an Outperform at Leerink

6d ago

Collegium Pharmaceutical assumed with a Buy at Truist

PremiumThe Fly

Collegium Pharmaceutical assumed with a Buy at Truist

6d ago

Collegium Pharmaceutical price target lowered to $48 from $56 at Barclays

PremiumThe Fly

Collegium Pharmaceutical price target lowered to $48 from $56 at Barclays

27d ago

Collegium Earnings Call: ADHD Growth vs. Pain Headwinds

PremiumCompany Announcements

Collegium Earnings Call: ADHD Growth vs. Pain Headwinds

27d ago

Collegium Pharmaceutical Launches $50 Million Accelerated Share Buyback

PremiumCompany AnnouncementsCollegium Pharmaceutical Launches $50 Million Accelerated Share Buyback

1M ago

Collegium Pharmaceutical Updates Guidance After AZSTARYS Acquisition

Company Announcements

Collegium Pharmaceutical Updates Guidance After AZSTARYS Acquisition

1M ago

Collegium Pharmaceutical Inc. (COLL) Q2 Earnings Cheat Sheet

Pre-Earnings

Collegium Pharmaceutical Inc. (COLL) Q2 Earnings Cheat Sheet

1M ago

Collegium Pharmaceutical to relocate corporate headquarters to Boston

PremiumThe Fly

Collegium Pharmaceutical to relocate corporate headquarters to Boston

2M ago

Collegium Pharma Leans on ADHD to Drive Growth

PremiumCompany Announcements

Collegium Pharma Leans on ADHD to Drive Growth

4M ago

Collegium Shareholders Back Board, Pay and Auditor Choices

PremiumCompany Announcements

Collegium Shareholders Back Board, Pay and Auditor Choices

4M ago

Collegium Pharmaceutical Completes AZSTARYS ADHD Business Acquisition

PremiumCompany Announcements

Collegium Pharmaceutical Completes AZSTARYS ADHD Business Acquisition

4M ago

Collegium Pharmaceutical Leans Into Growth After Earnings

PremiumCompany AnnouncementsCollegium Pharmaceutical Leans Into Growth After Earnings

4M ago

Collegium Reports Strong Q1 Results, Reaffirms 2026 Outlook

Company Announcements

Collegium Reports Strong Q1 Results, Reaffirms 2026 Outlook

4M ago

Collegium Pharmaceutical reports Q1 EPS $1.76, consensus $1.52

The Fly

Collegium Pharmaceutical reports Q1 EPS $1.76, consensus $1.52

4M ago

Collegium Pharmaceutical backs FY26 revenue view $805M-$825M, consensus $839.15M

PremiumThe Fly

Collegium Pharmaceutical backs FY26 revenue view $805M-$825M, consensus $839.15M

4M ago

Confident Leadership and Attractive Valuation Drive Buy Rating on Collegium (COLL)

PremiumRatings

Confident Leadership and Attractive Valuation Drive Buy Rating on Collegium (COLL)

5M ago

Collegium: Strategic AZSTARYS Acquisition Underpins ADHD Franchise Expansion and Supports Buy Rating

PremiumRatings

Collegium: Strategic AZSTARYS Acquisition Underpins ADHD Franchise Expansion and Supports Buy Rating

6M ago

Collegium Pharmaceutical to Acquire AZSTARYS ADHD Franchise

PremiumCompany Announcements

Collegium Pharmaceutical to Acquire AZSTARYS ADHD Franchise

6M ago

Collegium Pharmaceutical to acquire AZSTARYS for $650M in cash

PremiumThe FlyCollegium Pharmaceutical to acquire AZSTARYS for $650M in cash

6M ago

Collegium, Paris Hilton announce ‘Embrace Your Sparkle’ campaign

The Fly

Collegium, Paris Hilton announce ‘Embrace Your Sparkle’ campaign

7M ago

Collegium Pharmaceutical Earnings Call: Jornay Leads Growth

Company Announcements

Collegium Pharmaceutical Earnings Call: Jornay Leads Growth

7M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >